ADMA - ADMA Biologics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ADMA is currently covered by 4 analysts with an average price target of $22.2. This is a potential upside of $7.66 (52.68%) from yesterday's end of day stock price of $14.54.

ADMA Biologics's activity chart (see below) currently has 69 price targets and 57 ratings on display. The stock rating distribution of ADMA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 80.32% with an average time for these price targets to be met of 1081 days.

Highest price target for ADMA is $35, Lowest price target is $25, average price target is $29.5.

Most recent stock forecast was given by ELLIOT WILBUR from on 08-May-2025. First documented stock forecast 09-Sep-2015.

Currently out of the existing stock ratings of ADMA, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$32

$17.46 (120.08%)

$25

5 months 4 days ago
(08-May-2025)

5/7 (71.43%)

$10.8 (50.94%)

632

Buy

$35

$20.46 (140.72%)

$14

5 months 4 days ago
(08-May-2025)

8/9 (88.89%)

$13.8 (65.09%)

520

Buy

$25

$10.46 (71.94%)

$20

7 months 8 days ago
(03-Mar-2025)

8/9 (88.89%)

$7.99 (46.97%)

138

Buy

$26

$11.46 (78.82%)

$18

11 months 4 days ago
(07-Nov-2024)

14/15 (93.33%)

$3.38 (14.94%)

298

Buy

$4

$-10.54 (-72.49%)

$7

4 years 11 months 6 days ago
(05-Nov-2020)

6/6 (100%)

$2.09 (109.42%)

1736

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADMA (ADMA Biologics) average time for price targets to be met?

On average it took 1081 days on average for the stock forecasts to be realized with a an average price target met ratio 80.32

Which analyst has the current highest performing score on ADMA (ADMA Biologics) with a proven track record?

JASON KOLBERT

Which analyst has the current lower performing score on ADMA (ADMA Biologics) with a proven track record?

KEVIN DEGEETER

Which analyst has the most public recommendations on ADMA (ADMA Biologics)?

Jason Kolbert has 5 price targets and 5 ratings on ADMA

Which analyst is the currently most bullish on ADMA (ADMA Biologics)?

Anthony Petrone with highest potential upside - $20.46

Which analyst is the currently most reserved on ADMA (ADMA Biologics)?

Leland Gershell with lowest potential downside - -$10.54

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?